This notion has been challenged by mounting evidence of interaction between cerebrovascular disease and AD amyloid and tau pathologies (van Norden et al., 2012; Nucera and Hachinski, 2018; Solis et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.